Product/Composition:- | L-Ornithine L-Aspartate powder |
---|---|
Strength:- | 5 g, 10 g, or 15 g |
Form:- | Powder for Reconstitution for oral use |
Reference Brands:- | Liv.52, HepaMerz(EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
L-Ornithine L-Aspartate enhances hepatic ammonia detoxification by stimulating urea cycle activity in the liver. It helps reduce blood ammonia levels, supports liver function, and manages hepatic encephalopathy. Benefits include improved mental clarity, reduced neurotoxicity, and enhanced liver detoxification, supporting overall liver health and function.
L-Ornithine L-Aspartate powder is used extensively in Europe for managing hepatic encephalopathy and supporting liver function. In the EU, it is regulated as a medicinal product with dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans submitted to EMA. In the US, it is mainly available as compounded or compounded formulations, with limited commercial products approved. Dossiers should include comprehensive clinical and safety data, manufacturing details, and quality controls. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence facilitates timely approval, safe use, and wider availability, supporting liver health management worldwide.